Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Arthritis psoriatica].

M A de Rie1, A W R van Kuijk, A Y Goedkoop

  • 1Academisch Medisch Centrum/Universiteit van Amsterdam, Afd. Huidziekten, Amsterdam. m.a.derie@amc.uva.nl

Nederlands Tijdschrift Voor Geneeskunde
|September 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practical recommendations for seborrheic dermatitis management: An expert consensus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Successful implementation of handheld reflectance confocal microscopy as the standard of care in the (surgical) management of lentigo maligna (melanoma).

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Review of literature and clinical practice experience for the therapeutic management of Morgellons disease.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women.

Seminars in arthritis and rheumatism·2023
Same author

Lentigo maligna (melanoma): A systematic review and meta-analysis on surgical techniques and presurgical mapping by reflectance confocal microscopy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Myeloid Dendritic Cells Are Enriched in Lymph Node Tissue of Early Rheumatoid Arthritis Patients but not in At Risk Individuals.

Cells·2019

Psoriatic arthritis, affecting 6-39% of psoriasis patients, involves joint pain and inflammation. Early diagnosis and treatment with biologics targeting tumor necrosis factor (TNF) can prevent joint damage and improve quality of life.

Area of Science:

  • Rheumatology and Dermatology
  • Immunology
  • Pharmacology

Context:

  • Psoriatic arthritis (PsA) presents with diverse symptoms, from joint pain to severe erosive arthritis, affecting 6-39% of psoriasis patients.
  • Increased clinical awareness among dermatologists and rheumatologists leads to more frequent diagnoses of PsA.
  • Earlier diagnosis and intervention are crucial to prevent irreversible joint destruction in PsA patients.

Purpose:

  • To highlight the shared immunological pathways in psoriasis and PsA pathogenesis.
  • To emphasize the significance of tumor necrosis factor (TNF) as a key therapeutic target.
  • To discuss the impact of TNF-alpha-blocking agents on patient quality of life and understanding of acquired immunity in PsA.

Summary:

  • PsA symptoms range from arthralgia and enthesitis to chronic erosive arthritis.

Related Experiment Videos

  • Shared immunological mechanisms between psoriasis and PsA have identified common therapeutic targets, notably TNF.
  • TNF-alpha-blocking agents have shown significant success in treating PsA, improving patient quality of life and revealing the importance of acquired immunity.

    • Impact:

    • Successful treatment with TNF-alpha blockers has markedly improved the quality of life for many PsA patients.
    • Treatment advances have deepened the understanding of PsA pathogenesis, particularly the role of acquired immunity.
    • Guidelines for treating PsA with biologics have been developed by Dutch dermatology and rheumatology societies.